Portable Rapid Imaging for Medical Emergencies

NCT ID: NCT06930534

Last Updated: 2025-08-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

300 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-04-21

Study Completion Date

2026-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will compare the time it takes to scan a patient in the emergency department with a portable MRI when compared to a conventional MRI. Participants will be randomized to receive a portable MRI plus standard of care (SOC) vs SOC. Investigators will look at time to beginning of scan for both.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The primary objective of this study is to determine whether portable brain MRI reduces the time from scan order to scan start in the emergency department as compared to conventional brain MRI. The secondary objectives of this study are 1) to measure the percentage of scans that are completed after order and the time from order to completion, 2) to compare findings on portable MRI to conventional brain imaging findings, 3) to compare the total length of stay between the portable MRI and conventional MRI groups, and 4) to understand the impact of portable MRI scans on decision making and provider satisfaction based on qualitative surveys administered to a physician endpoint panel. This is a prospective, observational, randomized study. Participants will be recruited from the pool of patients ordered for a brain MRI, with or without contrast and excluding hyperacute MRI, in the emergency department. Participants will be randomized to one of two treatment groups, scan or standard-of-care (SOC). Participants in the scan arm will receive a portable MRI scan as soon as the scanner is available after randomization.

Participants in the SOC arm will not receive a portable MRI scan as part of their initial evaluation. Regardless of randomization arm, all participants will receive their scheduled conventional MRI as usual. Information on each participant's clinical course, conventional imaging, and length of stay will be collected, regardless of treatment group. On a rolling basis, surveys containing deidentified clinical information and portable MRI scans will be administered to a physician panel to assess the impact of portable MRI scans on decision making and provider satisfaction.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Patient Satisfaction Conventional Magnetic Resonance Imaging Portable Magnetic Resonance Imaging

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Portable Brain MRI scan

Participants in the scan arm will receive a portable MRI scan as soon as the scanner is available after randomization as part of their initial evaluation. Regardless of randomization arm, all participants will receive their scheduled conventional MRI as usual.

Group Type EXPERIMENTAL

Swoop Plus Mk2.0

Intervention Type DEVICE

portable brain MRI scanner

Standard of Care

Participants in the SOC arm will not receive a portable MRI scan as part of their initial evaluation. Regardless of randomization arm, all participants will receive their scheduled conventional MRI as usual.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Swoop Plus Mk2.0

portable brain MRI scanner

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female ≥ 18 years of age at presentation to Yale New Haven Hospital Adult ED
* Order to receive conventional brain MRI imaging originating in the YNHH Adult ED

Exclusion Criteria

* Lack of assent from treating physician for inclusion in this protocol.
* Contraindications to 1.5T MRI evaluation, including:

1. Cardiac Pacemaker or defibrillator
2. Aneurysm clip
3. Implants or devices attached to the body in the chest or above, such as:

1. Nerve stimulator
2. Deep brain stimulator
3. Programmable shunt
4. Stent
5. Pain pump
6. Artificial extremity
4. Implants in the ears (hearing aid or cochlear implant
5. Any shrapnel, pellets, bullets, metallic fragments, or other metallic foreign body above the chest
6. Metallic joints, rods, screws, or other orthopedic implants in or above the chest
7. Braces, dentures, removable teeth, or dental expanders that cannot be removed.
8. Body piercings in or above the chest that cannot be removed.
9. MRI-incompatible Tracheostomy tube or Swan Ganz catheter in place
10. Status Epilepticus or anyone previously seizing deemed by the physician not to be suitable for pMRI
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hyperfine

INDUSTRY

Sponsor Role collaborator

Yale University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Adam de Havenon, MD

Role: PRINCIPAL_INVESTIGATOR

Yale University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Yale New Haven Health Emergency Department

New Haven, Connecticut, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Adam H de Havenon, MD

Role: CONTACT

203-785-4085

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2000039013

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Ultrahigh Field Body MR Imaging
NCT02236143 ENROLLING_BY_INVITATION
AI-powered Portable MRI Abnormality Detection
NCT06803420 NOT_YET_RECRUITING NA